Susan Fox, director, business and product development, US Script, Inc, says the prescription benefit provides a unique opportunity to attract, attain, serve, and retain members in exchange insurance plans
Susan Fox, director, business and product development, US Script, Inc, says the prescription benefit provides a unique opportunity to attract, attain, serve, and retain members in exchange insurance plans. For one, the health insurance marketplace (HIM) creates a shift by changing how individuals access and sponsors provide prescription drug benefits—in much the same way as Medicare Part D changed how employers provide retiree prescription drug benefits.
Ms Fox says the HIM is both unique and important to exchange offerings. It is unique in that it offers real-time claim processing and precise claim data, and helps facilitate an increasingly collaborative network. It is important because more than half of Americans take at least 1 prescription per year, prescriptions account more than 10% of medical spending, and the HIM can complement medical procedures as well as reduce medical spend.
“The good news for everyone is that there’ll be a larger covered population,” Fox said. She added that providers and payers will be covering a new population, but they will also be changing how care has been delivered to previously covered populations. “So our business relationships will likely be more close, more intense,” she added.
Other key effects of the Affordable Care Act (ACA) include increasing plan options for employers, providing more options for enrollees as buyers, creating additional risk management needs, and enhancing business models.
Ms Fox pointed out that 36 states have opted to offer federally facilitated marketplaces 2014. However, this is also a trend toward private exchanges. Participants in these private exchanges include employers, other sponsors, and coalitions. They enable an employer to shift to a defined contribution model, shift risk from employer to health plans, and favor “carved-in drug benefit.” Health plans that take on that shift in increased risk will look for ways to manage care, manage costs, and attract/retain plan enrollees.
Ms Fox says that while there is an increased opportunity to leverage the pharmacy benefit, there may be a disruption to PBM-employer relationships.
Additional coverage from the PBMI conference available here: http://bit.ly/1gm7PXj
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
A global AIDS program that was in limbo for months got temporary relief after congressional negotiators agreed to a 1-year renewal in the next government funding package; the outcome of the November presidential election could determine the state of fetal tissue research in the US; federal officials and industry executives failed to make improvements that stop hacking attacks.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Fragmented Payer System, Vulnerable Supply Chain Among Threats to Accessing Essential Medicines
March 13th 2024During a session of the 2024 V-BID Summit, panelists Stacie Dusetzina, PhD, and Inma Hernandez, PharmD, PhD, discussed how access to essential medications is curtailed not just by the longstanding complexities of insurance design but also by emerging threats such as supply chain weaknesses and cyberattacks.
Read More
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More